5S rRNA modificator - CAS 1415238-77-5
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
5S rRNA modificator
Catalog Number:
1415238-77-5
Synonyms:
5S rRNA modificator
CAS Number:
1415238-77-5
Description:
5S rRNA modificator is a suitable electrophile for 2’-hydroxyl acylation on structured RNA molecules, yielding accurate structural information comparable to that obtained with existing probes; 5S rRNA RNA modification.
Molecular Weight:
176.17
Molecular Formula:
C9H8N2O2
COA:
Inquire
MSDS:
Inquire
Targets:
Others
Chemical Structure
CAS 1415238-77-5 5S rRNA modificator

Related Products


CAS 42017-89-0 Fenofibric acid

Fenofibric acid
(CAS: 42017-89-0)

Fenofibric acid is a lipid regulating agent available as delayed release capsules for oral administration.

CAS 739-71-9 trimipramine

trimipramine
(CAS: 739-71-9)

Trimipramine is a tricyclic antidepressant. It is serotonin and norepinephrine transport inhibitor with antipsychotic and sedative properties.

CAS 481-46-9 Ginkgetin

Ginkgetin
(CAS: 481-46-9)

Ginkgetin is a natural biflavonoid isolated from leaves of Ginkgo biloba L. According to reports, it has anti-inflammatory and anti-cancer effects.

CAS 110267-81-7 Amrubicin

Amrubicin
(CAS: 110267-81-7)

Amrubicin is a novel anthracycline derivative for treatment of bladder carcinoma.

CAS 22608-11-3 Demethoxycurcumin

Demethoxycurcumin
(CAS: 22608-11-3)

Natural demethoxy curcuminoid. Anticancer, antiproliferative and antioxidant activity. Inhibits various signaling pathways including Wnt/β-catenin, AMPK and MAP...

Bisegliptin
(CAS: 862501-61-9)

Bisegliptin is an antidiabetic agent, but no detailed information has been published yet.

KHK-IN-1
(CAS: 1303469-70-6)

KHK-IN-1, a pyrimidinopyrimidine derivative, is a ketohexokinase inhibitor that could have probable effect against diabetes and obesity by acting on Asp-27B in ...

SR9011
(CAS: 1379686-29-9)

SR9011, a synthetic REV-ERB agonist, has been found to have probable effect against sleep disorders and metabolic diseases. IC50: 790 nM and 560 nM for Rev-ErbB...

CAS 512-04-9 Diosgenin

Diosgenin
(CAS: 512-04-9)

Diosgenin, a steroid sapogenin, is the product of hydrolysis by acids, strong bases, or enzymes of saponins, extracted from the tubers of Dioscorea wild yam, su...

CAS 67920-52-9 Sodium Danshensu

Sodium Danshensu
(CAS: 67920-52-9)

Sodium Danshensu is a mono sodium of danshensu, which is a natural phenolic acid of caffeic acid derivatives isolated from Salvia miltiorrhiza.

CAS 41060-15-5 Neobavaisoflavone

Neobavaisoflavone
(CAS: 41060-15-5)

Neobavaisoflavone significantly inhibited the production of reactive oxygen species (ROS), reactive nitrogen species (RNS) and cytokines: IL-1β, IL-6, IL-12p40,...

CAS 144675-97-8 Pixantrone Maleate

Pixantrone Maleate
(CAS: 144675-97-8)

Pixantrone is a synthetic, noncardiotoxic aza-anthracenedione analogue with potential antineoplastic activity. Pixantrone intercalates into DNA and induces topo...

CAS 3184-59-6 Alipamide

Alipamide
(CAS: 3184-59-6)

Alipamide is a bio-active chemical with a sequence-specific threading tetra-intercalator with an extremely slow dissociation rate constant.

CAS 123-82-0 2-Aminoheptane

2-Aminoheptane
(CAS: 123-82-0)

2-Aminoheptane, a fatty Amine compound, is commonly used in proteomics research and could also be used to product some A3 adenosine receptor antagonists.

CP-67804
(CAS: 103978-08-1)

CP-67804 enhances topoisomerase II-mediated DNA cleavage. It represent a novel class of topoisomerase II-targeted drugs which have potential as antineoplastic a...

BTZ-N3
(CAS: 1839081-05-8)

BTZ-N3, a electron deficient nitroaromatic compound, is a potent and selective anti-TB drug candidate.

CAS 98753-19-6 Cefpirome Sulfate

Cefpirome Sulfate
(CAS: 98753-19-6)

Cefpirome Sulfate is a fourth generation cephalosporin antibiotic. It was developed by German company Hoechst and France Roussel company together.

ARQ 736
(CAS: 1228237-47-5)

CAS 491-70-3 Luteolin

Luteolin
(CAS: 491-70-3)

Luteolin is a flavonoid found in Terminalia chebula, which is a non-selective phisphodiesterase PDE inhibitor.

CAS 152646-95-2 Ono-4007 sodium salt

Ono-4007 sodium salt
(CAS: 152646-95-2)

The sodium salt form of Ono-4007, a partial analogue of bacterial lipopolysaccharide, has been found to stimulate tumor necrosis factor so that could be useful ...

Reference Reading


1.RNomics and Modomics in the halophilic archaea Haloferax volcanii: identification of RNA modification genes.
Grosjean H1, Gaspin C, Marck C, Decatur WA, de Crécy-Lagard V. BMC Genomics. 2008 Oct 9;9:470. doi: 10.1186/1471-2164-9-470.
BACKGROUND: Naturally occurring RNAs contain numerous enzymatically altered nucleosides. Differences in RNA populations (RNomics) and pattern of RNA modifications (Modomics) depends on the organism analyzed and are two of the criteria that distinguish the three kingdoms of life. If the genomic sequences of the RNA molecules can be derived from whole genome sequence information, the modification profile cannot and requires or direct sequencing of the RNAs or predictive methods base on the presence or absence of the modifications genes.
2.Direct regulation of tRNA and 5S rRNA gene transcription by Polo-like kinase 1.
Fairley JA1, Mitchell LE, Berg T, Kenneth NS, von Schubert C, Silljé HH, Medema RH, Nigg EA, White RJ. Mol Cell. 2012 Feb 24;45(4):541-52. doi: 10.1016/j.molcel.2011.11.030. Epub 2012 Jan 25.
Polo-like kinase Plk1 controls numerous aspects of cell-cycle progression. We show that it associates with tRNA and 5S rRNA genes and regulates their transcription by RNA polymerase III (pol III) through direct binding and phosphorylation of transcription factor Brf1. During interphase, Plk1 promotes tRNA and 5S rRNA expression by phosphorylating Brf1 directly on serine 450. However, this stimulatory modification is overridden at mitosis, when elevated Plk1 activity causes Brf1 phosphorylation on threonine 270 (T270), which prevents pol III recruitment. Thus, although Plk1 enhances net tRNA and 5S rRNA production, consistent with its proliferation-stimulating function, it also suppresses untimely transcription when cells divide. Genomic instability is apparent in cells with Brf1 T270 mutated to alanine to resist Plk1-directed inactivation, suggesting that chromosome segregation is vulnerable to inappropriate pol III activity.
3.Small ubiquitin-like modifier (SUMO)-mediated repression of the Xenopus Oocyte 5 S rRNA genes.
Malik MQ1, Bertke MM1, Huber PW2. J Biol Chem. 2014 Dec 19;289(51):35468-81. doi: 10.1074/jbc.M114.609123. Epub 2014 Nov 3.
The 5 S rRNA gene-specific transcription factor IIIA (TFIIIA) interacts with the small ubiquitin-like modifier (SUMO) E3 ligase PIAS2b and with one of its targets, the transcriptional corepressor, XCtBP. PIAS2b is restricted to the cytoplasm of Xenopus oocytes but relocates to the nucleus immediately after fertilization. Following the midblastula transition, PIAS2b and XCtBP are present on oocyte-type, but not somatic-type, 5 S rRNA genes up through the neurula stage, as is a limiting amount of TFIIIA. Histone H3 methylation, coincident with the binding of XCtBP, also occurs exclusively on the oocyte-type genes. Immunohistochemical staining of embryos confirms the occupancy of a subset of the oocyte-type genes by TFIIIA that become positioned at the nuclear periphery shortly after the midblastula transition. Inhibition of SUMOylation activity relieves repression of oocyte-type 5 S rRNA genes and is correlated with a decrease in methylation of H3K9 and H3K27 and disruption of subnuclear localization.